This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Are Investors Undervaluing Centene (CNC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Value Trader Highlights: Centene, Diamondback Energy, The Kroger, Wells Fargo and United Rentals
by Zacks Equity Research
Centene, Diamondback, Energy, The Kroger, Wells Fargo and United Rentals are part of Zacks Value Trader blog.
Make a Wish List of Value Stocks
by Tracey Ryniec
Screen with the Zacks Rank and Style Scores to find top companies.
Factors That Make Centene (CNC) an Attractive Bet for Investors
by Zacks Equity Research
Centene (CNC) rides on continued top-line growth and numerous contract wins. Divestitures and an adequate cash-generating ability equip CNC well to invest in growth-related initiatives.
Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS
by Zacks Equity Research
Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.
Centene's (CNC) Contract Win to Aid Nebraska's Medicaid Members
by Zacks Equity Research
The Nebraska DHHS awards a contract to Centene's (CNC) Nebraska arm to continue serving the unmet need of the state's Medicaid members with a suite of better healthcare options.
Centene (CNC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Centene (CNC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
UnitedHealth (UNH) Wins New Medicaid Contract in Nebraska
by Zacks Equity Research
UnitedHealth's (UNH) UnitedHealthcare boasts a network of 100 hospitals and more than 14,000 physicians and caregivers in Nebraska.
This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks Industry Outlook Highlights UnitedHealth Group, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth Group, Humana, Centene and Molina Healthcare are part of Zacks Industry Outlook article.
4 HMO Stocks to Watch Despite Escalating Technology Expenses
by Debasmita Chatterjee
A growing customer base and numerous contract wins might drive the Medical-HMO industry. However, high expenses related to technology advancements and a shortage of nurses will dampen margins. Stocks like UNH, HUM, CNC and MOH will likely ride out the industry storms.
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $83.41, moving -1.6% from the previous trading session.
Centene (CNC) Wins Contract to Serve Texas' Foster Population
by Zacks Equity Research
Centene's (CNC) Texas subsidiary secures a contract to continue catering to the state's foster children and youth via its Medicaid plans.
Humana (HUM) Surges 8.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Humana (HUM) Hikes Guidance: Here's Why It's a Good Sign
by Zacks Equity Research
Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $92.90, moving +0.99% from the previous trading session.
Should Vanguard MidCap Growth ETF (VOT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOT
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $88.33 in the latest trading session, marking a -1.91% move from the prior day.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa
by Zacks Equity Research
Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.
Is Centene (CNC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $89.74, marking a -1.59% move from the previous day.
Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties
by Zacks Equity Research
Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.
If You Invested $1000 in Centene 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Is Alimera Sciences (ALIM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Alimera Sciences (ALIM) and Centene (CNC) have performed compared to their sector so far this year.